Why alcohol can briefly lift mood during withdrawal
Biochemical Studies Underlying Acute Ethanol's Antidepressant-like effects during Withdrawal in a Preclinical Model of Ethanol Dependence
This work looks at biochemical changes that let alcohol briefly reduce depression-like symptoms during withdrawal to help understand mood problems in people with alcohol dependence and depression.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project ID | NIH-11326722 on NIH RePORTER |
What this research studies
Researchers use animal models that mimic chronic drinking and withdrawal to see how a single dose of alcohol changes behavior linked to low mood and loss of pleasure. They focus on a brain protein called Fragile X Mental Retardation Protein (FMRP) and related synaptic proteins, and compare alcohol's effects with drugs that block NMDA receptors. The team measures depression- and anhedonia-like behaviors and examines biochemical and synapse changes in the brain. The goal is to explain how a short mood lift from alcohol can shift to worsened mood during withdrawal.
Who could benefit from this research
Good fit: People with alcohol use disorder who experience withdrawal-related depression, anxiety, or loss of pleasure (anhedonia) would be the patient group most relevant to this research.
Not a fit: People whose depression is unrelated to alcohol use or who do not experience withdrawal symptoms are unlikely to receive direct benefit from this project.
Why it matters
Potential benefit: If successful, this work could point to new treatments that mimic alcohol's rapid mood-lifting effects without the harms of drinking, helping people with alcohol-related depression.
How similar studies have performed: Previous animal studies have shown similar rapid antidepressant-like effects from alcohol and NMDA receptor antagonists and implicate FMRP, but translating these findings into safe human treatments is still unproven.
Where this research is happening
Winston-Salem, United States
- Wake Forest University Health Sciences — Winston-Salem, United States (Active)
Researchers
- Principal investigator: Raab-Graham, Kimberly Frances — Wake Forest University Health Sciences
- Study coordinator: Raab-Graham, Kimberly Frances
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.